Results 11 to 20 of about 6,386 (141)
Foscarnet-Associated Penile Ulcerations
, 1994 Objective: To report a case of foscarnet-induced penile ulcerations and review literature related to this adverse effect. Data Sources: Case reports and review articles identified by a computerized search (MEDLINE) and manual search (Index Medicus). Data
Richard M. Cadle, Richard J. Hamill
core +1 more source
eJHaem, Volume 7, Issue 3, June 2026.ABSTRACT Introduction Safe outpatient delivery of B‐cell maturation antigen–targeting bispecific antibodies (BCMA‐BsAbs) in multiple myeloma (MM) is challenging, particularly during step‐up dosing (SUD). Standardized guidance for European community practice is limited.
María‐Victoria Mateos +10 more
wiley +1 more source
Inhibitory effects of foscarnet on herpesvirus multiplication in cell culture
, 1981 The effect of phosphonoformate (INN; foscarnet sodium) on Herpes Simplex Virus type 1 replication in cell-culture has been studied. At 55 μm, foscarnet reduced the yield by 50 per cent which correlated well with a 50 per cent reduction of plaque ...
Schnürer, Johan,, Öberg, B.,
core +1 more source
Basic &Clinical Pharmacology &Toxicology, Volume 138, Issue 6, June 2026.ABSTRACT Vancomycin (VCM) is essential for treating methicillin‐resistant Staphylococcus aureus infections, but its use is limited by vancomycin‐induced nephrotoxicity (VIN). Although preclinical and small clinical studies suggest a protective role for vitamin E, real‐world evidence remains limited.
Satoru Nakanishi +6 more
wiley +1 more source
Maribavir for Cytomegalovirus Infection in High‐Risk Kidney Transplant Recipients: A Case Series
IJU Case Reports, Volume 9, Issue 3, May 2026.ABSTRACT Background Cytomegalovirus (CMV) infection remains a common complication after kidney transplantation, particularly among high‐risk donor‐seropositive/recipient‐seronegative (D+/R−) recipients. Valganciclovir is the standard first‐line therapy; however, its use may be limited by hematological toxicity or impaired graft function. Maribavir is a
Daiji Takamoto +6 more
wiley +1 more source
Foscarnet-induced penile ulceration [PDF]
, 2011 Foscarnet is used to treat infections with herpes viruses, including drug-resistant cytomegalovirus (CMV) and infections with herpes viruses 1 and 2 (HSV-1 and HSV-2). There are some reports of intravenous foscarnet-induced penile and vulvar ulceration.
Fernandes, I. +3 more
core
Removal of Foscarnet by Hemodialysis using Dialysate-Side Values
, 2000 Foscarnet is an antiviral agent widely used in the treatment of cytomegalovirus (CMV) infection. We describe a cardiac transplant patient, who while being maintained with hemodialysis because of tobramycin-induced acute renal failure, was given ...
J.G. Gambertoglio +5 more
core +1 more source
Reviews in Medical Virology, Volume 36, Issue 3, May 2026.ABSTRACT Human cytomegalovirus (HCMV) reactivation is a common and significant complication after allogeneic haematopoietic stem cell transplantation (allo‐HSCT), causing potentially life‐threatening disease. Antiviral therapy approaches for HCMV are often limited by toxicities and the risk of developing antiviral drug resistance.
Gaurav Sutrave +7 more
wiley +1 more source
Foscarnet-induced genital lesions: An overview with a case report
, 2018 Foscarnet is an important antiviral medication used mainly in the treatment of complicated Herpes-simplex virus and cytomegalovirus (CMV) infections. Reported first in the 1990’s, genital ulcers are a potential side effect in about 10% of cases.
Jonathan Ungar +3 more
core +1 more source
Reviews in Medical Virology, Volume 36, Issue 3, May 2026.ABSTRACT Human cytomegalovirus (HCMV) is one of the most important opportunistic pathogens in immunocompromised individuals, including allogeneic haematopoietic stem cell transplant (allo‐HSCT) recipients. In allo‐HSCT, HCMV seropositivity of the recipient and donor is associated with inferior survival outcomes, and post‐transplant HCMV reactivation is
Danya Kaplan +7 more
wiley +1 more source